CVRdatabase
Menu

Reapplix A/S

Public limited companyCVR 31261570BirkerødActive

Reapplix A/S is a public limited company, based in Birkerød, active in research and experimental development on natural sciences and engineering, founded in 2008. The company made a loss in both 2024 and 2025, most recently DKK 48.3m. Gross profit is higher than that of 89% of the companies in the industry in the database. 8 people are registered in the company's management and ownership.

Follow
PDF reportCompare

Key figures · financial year 2025

RevenueDKK 28.4m+93.2% vs. 2024
Net profit−DKK 48.3m−27.9% vs. 2024
EquityDKK 18.4m+2.7% vs. 2024
Employees8latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit rose 115% (2024 → 2025), to DKK 24.5m.
  • Revenue rose 93% (2024 → 2025), to DKK 28.4m.
  • The loss grew: from DKK 37.8m to DKK 48.3m (2024 → 2025).
  • Equity rose 3% (2024 → 2025), to DKK 18.4m.

Employees

  • 1 fewer employees than a year earlier: 8 (08/2026) against 9 (08/2025).

Management and owners, last 24 months

  • New owners registered: Seed Capital Denmark Ii K/S (10/04/2026) and Lauxera Growth I S.L.P (10/04/2026).
  • No longer registered as owner: Seed Capital Denmark Ii K/S (09/04/2026) and Lauxera Growth I S.L.P (09/04/2026).

Registrations, last 24 months

  • 10/04/2026: Share capital changed from 8,540,331 DKK to 9,171,494 DKK
  • 17/01/2025: Share capital changed from 7,745,678 DKK to 8,540,331 DKK
  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 60m−DKK 40m−DKK 20mDKK 0DKK 20mDKK 40mDKK 60mDKK 80m202020212022202320242025
EquityNet profit
Financial figures for Reapplix A/S
202020212022202320242025Change
Revenue7331,6114,3847,19014,69628,389+93.2%
Gross profit4379402,8732,99111,42924,535+114.7%
Operating profit (EBIT)−36,559−37,845−52,027−43,735−45,028−36,442+19.1%
Profit before tax−37,165−33,178−46,599−47,138−38,769−48,917−26.2%
Net profit−35,384−31,416−45,019−45,870−37,762−48,282−27.9%
Total assets58,69181,72334,83369,90226,35524,494−7.1%
Equity43,49172,74026,02860,64417,89718,372+2.7%
Liabilities15,2008,9838,8049,2588,4586,122−27.6%
Cash and cash equivalents47,62271,89020,64155,59210,7147,661−28.5%
Average number of employees13012232428+16.7%

Source: annual reports filed with the Danish Business Authority (XBRL). Group figures; change is the latest year against the year before. “–” means the figure is not stated in the annual report.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 5mDKK 10mDKK 15mDKK 20mDKK 25m202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Loss for 6 years in a row

    Net result has been negative in 2020–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Reapplix A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202502/07/2026The groupPDF not statedXBRL
202401/01/2024 – 31/12/202430/06/2025The groupPDFXBRL
202301/01/2023 – 31/12/202302/07/2024The groupPDFXBRL
202201/01/2022 – 31/12/202229/06/2023The companyPDFXBRL
202101/01/2021 – 31/12/202101/07/2022The companyPDFXBRL
202001/01/2020 – 31/12/202007/07/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
024681009/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profitDKK 24.5mNo. 48 of 421
Better than 89% of the companies in the industry
EquityDKK 18.4mNo. 107 of 431
Better than 75% of the companies in the industry
Number of employees8No. 66 of 431
Better than 85% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bnHere
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 1,121of 69,742
Better than 98%
No. 6,117of 69,964
Better than 91%
Same industry and fewer than 20 employees329 companies in the comparison
No. 8of 323
Better than 98%
No. 43of 329
Better than 87%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 2,830of 24,791
Better than 89%
No. 4,688of 24,909
Better than 81%
All companies of type A/S18,025 companies in the comparison
No. 5,092of 17,786
Better than 71%
No. 6,476of 18,024
Better than 64%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Reapplix A/SDKK 24.5m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Reapplix A/S−DKK 48.3m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Reapplix A/SDKK 18.4m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Reapplix A/S8
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
Reapplix A/S

Management

8 active registrations

Executive management

Executive management at Reapplix A/S
NameRoleAppointed
Morten Have-RasmussenDirector03/07/2018

Board of directors

Board of directors at Reapplix A/S
NameRoleAppointed
Tonni Bülow-NielsenBoard member31/01/2013
Søren MøllerBoard member31/01/2013
Bo Jesper HansenBoard member28/07/2020
Samuel LevyBoard member28/07/2020
Kira Paniagua RupprechtBoard member30/06/2021
Klaus Eldrup-JørgensenChair of the board30/04/2024
Jørgen Ulrik VejlsgaardBoard member30/04/2024
Founders
Lundquist Medical ApS, N. E. Holm A/S
Former management (20)
Former management at Reapplix A/S
NameRoleAppointedResigned
Rasmus LundquistBoard member19/02/200827/02/2019
Rasmus LundquistAssistant director19/02/200831/05/2023
Bo Jesper HansenChair of the board22/07/200915/03/2013
Line Holten ReimerBoard member22/07/200909/01/2015
Carsten SchouBoard member30/06/201004/02/2014
Peter Gerhard Friedrich HentschelChair of the board15/03/201328/07/2020
Ulf Lennart RosénBoard member04/02/201421/10/2020
Niels Erik HolmAssistant director02/09/201402/11/2021
Graeme Nigel BrookesCEO02/09/201401/01/2021
Ulrik SporkBoard member27/02/201927/07/2020
Birgit Aagaard-SvendsenBoard member27/02/201928/07/2020
Cyrille Yann Nicolas PetitBoard member14/05/201926/06/2023
Ulrik SporkChair of the board28/07/202031/12/2020
Klaus Eldrup-JørgensenBoard member28/07/202029/04/2024
Jørgen Ulrik VejlsgaardBoard member28/07/202012/12/2023
Richard TwomeyBoard member19/10/202031/12/2020
Ulrik SporkDeputy chair01/01/202126/06/2023
Richard TwomeyChair of the board01/01/202112/12/2023
Jørgen Ulrik VejlsgaardChair of the board13/12/202329/04/2024
Richard TwomeyBoard member13/12/202328/06/2024

Signing rule: Selskabet tegnes af tre bestyrelsesmedlemmer eller af selskabets administrerende direktør og bestyrelsesformanden i forening.

Address and production units

1 active production units

Bregnerødvej 133
3460 Birkerød

Rudersdal Municipality · Postcode 3460

Other companies at the address (1)

Production units
Production unitAddressEmployeesP number
Reapplix A/SBregnerødvej 133, st, 3460 Birkerød81014194106

Purpose

Selskabets formål er at drive en virksomhed der udvikler og sælger et device der producerer fibrin dressing til brug for sårpleje og dermed beslægtet virksomhed.

The purpose is quoted from the register in Danish.

Changes year by year

138 registered events
20266 changesaccounts 1 · capital 1 · ownership 4
  • Annual report for 2025 published
  • Share capital changed from 8,540,331 DKK to 9,171,494 DKK
  • Lauxera Growth I S.L.P registered as owner (10%)
  • SEED CAPITAL DENMARK II K/S registered as owner (5%)
  • Lauxera Growth I S.L.P is no longer registered as owner
  • SEED CAPITAL DENMARK II K/S is no longer registered as owner
20253 changesaccounts 1 · capital 1 · industry 1
  • Annual report for 2024 published
  • Share capital changed from 7,745,678 DKK to 8,540,331 DKK
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20248 changesaccounts 1 · management 5 · ownership 2
  • Annual report for 2023 published
  • Richard Twomey stepped down as board member
  • Jørgen Ulrik Vejlsgaard appointed board member
  • Klaus Eldrup-Jørgensen appointed chair of the board
  • Jørgen Ulrik Vejlsgaard stepped down as chair of the board
  • Klaus Eldrup-Jørgensen stepped down as board member
  • MK VENTURES ApS registered as owner (10%)
  • MK VENTURES ApS is no longer registered as owner
202329 changesmanagement 7 · ownership 20 · accounts 1 · capital 1
  • Jørgen Ulrik Vejlsgaard appointed chair of the board
  • Richard Twomey appointed board member
  • Richard Twomey stepped down as chair of the board
  • Jørgen Ulrik Vejlsgaard stepped down as board member
  • North-East Health Care Holding ApS registered as owner (10%)
  • North-East Health Care Investment ApS is no longer registered as owner
  • Annual report for 2022 published
  • Ulrik Spork stepped down as deputy chair
  • Cyrille Yann Nicolas Petit stepped down as board member
  • Rasmus Lundquist stepped down as assistant director
  • Share capital changed from 6,062,388 DKK to 7,745,678 DKK
  • Bo Jesper Hansen registered as owner (5%)
  • Lauxera Growth I S.L.P registered as owner (5%)
  • North-East Health Care Investment ApS registered as owner (5%)
  • MK VENTURES ApS registered as owner (5%)
  • SEED CAPITAL DENMARK II K/S registered as owner (10%)
  • Danmarks Eksport- og Investeringsfond registered as owner (15%)
  • Novo Holdings A/S registered as owner (15%)
  • Jan Struve registered as owner (5%)
  • Danmarks Eksport- og Investeringsfond is no longer registered as owner
  • Lauxera Growth I S.L.P is no longer registered as owner
  • SEED CAPITAL DENMARK II K/S is no longer registered as owner
  • MK VENTURES ApS is no longer registered as owner
  • North-East Health Care Investment ApS is no longer registered as owner
  • Novo Holdings A/S is no longer registered as owner
  • Jan Struve is no longer registered as owner
  • Bo Jesper Hansen is no longer registered as owner
  • Danmarks Eksport- og Investeringsfond registered as owner (15%)
  • VÆKSTFONDEN is no longer registered as owner
20225 changesaccounts 1 · address 1 · ownership 2 · capital 1
  • Annual report for 2021 published
  • Moved to Bregnerødvej 133, st, 3460 Birkerød
  • Lauxera Growth I S.L.P registered as owner (5%)
  • Lauxera Growth Opportunity 1 is no longer registered as owner
  • Share capital changed from 5,375,087 DKK to 6,062,388 DKK
202113 changesmanagement 5 · accounts 1 · capital 1 · ownership 6
  • Niels Erik Holm stepped down as assistant director
  • Annual report for 2020 published
  • Share capital changed from 4,355,071 DKK to 5,375,087 DKK
  • SEED CAPITAL DENMARK II K/S registered as owner (15%)
  • MK VENTURES ApS registered as owner (5%)
  • North-East Health Care Investment ApS registered as owner (5%)
  • Lauxera Growth Opportunity 1 registered as owner (5%)
  • N. E. HOLM A/S is no longer registered as owner
  • Kira Paniagua Rupprecht appointed board member
  • SEED CAPITAL DENMARK II K/S is no longer registered as owner
  • Ulrik Spork appointed deputy chair
  • Richard Twomey appointed chair of the board
  • Graeme Nigel Brookes stepped down as ceo
202021 changesmanagement 12 · capital 1 · ownership 8
  • Richard Twomey stepped down as board member
  • Ulrik Spork stepped down as chair of the board
  • Ulf Lennart Rosén stepped down as board member
  • Richard Twomey appointed board member
  • Jørgen Ulrik Vejlsgaard appointed board member
  • Ulrik Spork appointed chair of the board
  • Klaus Eldrup-Jørgensen appointed board member
  • Bo Jesper Hansen appointed board member
  • Samuel Levy appointed board member
  • Birgit Aagaard-Svendsen stepped down as board member
  • Peter Gerhard Friedrich Hentschel stepped down as chair of the board
  • Ulrik Spork stepped down as board member
  • Share capital changed from 2,818,893 DKK to 4,355,071 DKK
  • Novo Holdings A/S registered as owner (15%)
  • VÆKSTFONDEN registered as owner (15%)
  • SEED CAPITAL DENMARK II K/S registered as owner (20%)
  • Jan Struve registered as owner (5%)
  • Bo Jesper Hansen registered as owner (5%)
  • SEED CAPITAL DENMARK II K/S is no longer registered as owner
  • Novo Holdings A/S is no longer registered as owner
  • VÆKSTFONDEN is no longer registered as owner
20198 changescapital 1 · ownership 3 · management 4
  • Share capital changed from 2,370,528 DKK to 2,818,893 DKK
  • SEED CAPITAL DENMARK II K/S registered as owner (25%)
  • Lundquist Medical ApS is no longer registered as owner
  • SEED CAPITAL DENMARK II K/S is no longer registered as owner
  • Cyrille Yann Nicolas Petit appointed board member
  • Birgit Aagaard-Svendsen appointed board member
  • Ulrik Spork appointed board member
  • Rasmus Lundquist stepped down as board member
20185 changesname 1 · capital 3 · management 1
  • Name changed from REAPPLIX ApS to Reapplix A/S
  • Share capital changed from 2,110,761 DKK to 2,370,528 DKK
  • Share capital changed from 1,844,352 DKK to 2,110,761 DKK
  • Morten Have-Rasmussen appointed director
  • Share capital changed from 1,389,210 DKK to 1,844,352 DKK
20162 changesaddress 1 · capital 1
  • Moved to Blokken 45, 3460 Birkerød
  • Share capital changed from 1,373,690 DKK to 1,389,210 DKK
201511 changesownership 9 · management 1 · capital 1
  • N. E. HOLM A/S registered as owner (5%)
  • SEED CAPITAL DENMARK II K/S registered as owner (33.33%)
  • Novo Holdings A/S registered as owner (20%)
  • VÆKSTFONDEN registered as owner (20%)
  • PreSeed Ventures A/S is no longer registered as owner
  • VÆKSTFONDEN is no longer registered as owner
  • SEED CAPITAL DENMARK II K/S is no longer registered as owner
  • Novo Holdings A/S is no longer registered as owner
  • N. E. HOLM A/S is no longer registered as owner
  • Line Holten Reimer stepped down as board member
  • Share capital changed from 954,503 DKK to 1,373,690 DKK
20144 changesmanagement 4
  • Niels Erik Holm appointed assistant director
  • Graeme Nigel Brookes appointed ceo
  • Ulf Lennart Rosén appointed board member
  • Carsten Schou stepped down as board member
201311 changesownership 6 · management 4 · capital 1
  • PreSeed Ventures A/S registered as owner (5%)
  • VÆKSTFONDEN registered as owner (15%)
  • SEED CAPITAL DENMARK II K/S registered as owner (33.33%)
  • Novo Holdings A/S registered as owner (15%)
  • N. E. HOLM A/S registered as owner (10%)
  • Lundquist Medical ApS registered as owner (5%)
  • Peter Gerhard Friedrich Hentschel appointed chair of the board
  • Bo Jesper Hansen stepped down as chair of the board
  • Share capital changed from 431,430 DKK to 954,503 DKK
  • Tonni Bülow-Nielsen appointed board member
  • Søren Møller appointed board member
20121 changecapital 1
  • Share capital changed from 393,930 DKK to 431,430 DKK
20112 changescapital 2
  • Share capital changed from 368,930 DKK to 393,930 DKK
  • Share capital changed from 318,930 DKK to 368,930 DKK
20102 changescapital 1 · management 1
  • Share capital changed from 286,430 DKK to 318,930 DKK
  • Carsten Schou appointed board member
20093 changescapital 1 · management 2
  • Share capital changed from 250,715 DKK to 286,430 DKK
  • Line Holten Reimer appointed board member
  • Bo Jesper Hansen appointed chair of the board
20084 changescapital 1 · management 2 · founded 1
  • Share capital changed from 187,500 DKK to 250,715 DKK
  • Rasmus Lundquist appointed board member
  • Rasmus Lundquist appointed assistant director
  • Registered as REAPPLIX ApS

Related companies

Same industry in Rudersdal

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction